Free Trial
NYSEAMERICAN:AZTR

Azitra (AZTR) Stock Price, News & Analysis

Azitra logo
$0.61 -0.06 (-8.99%)
Closing price 11/13/2026 04:10 PM Eastern
Extended Trading
$0.60 0.00 (-0.56%)
As of 11/13/2026 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Azitra Stock (NYSEAMERICAN:AZTR)

Advanced

Key Stats

Today's Range
$0.61
▼
$0.67
50-Day Range
$0.59
▼
$7.15
52-Week Range
$0.52
▼
$3.91
Volume
80,169 shs
Average Volume
8.15 million shs
Market Capitalization
$3.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Azitra, Inc. is a biotechnology company developing treatments for skin diseases using live biotherapeutic products based on bacteria that naturally inhabit the skin. Its approach includes engineering skin-associated bacteria to deliver therapeutic proteins directly to the skin.

The company’s pipeline includes ATR-12, a candidate being developed for Netherton syndrome, a rare genetic skin disorder, and ATR-04, a candidate intended to address skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitor cancer treatments. These programs remain investigational and are not approved treatments.

Based in Branford, Connecticut, Azitra is focused on research and development rather than marketing commercially available products. Its work applies microbiome science and engineered bacteria to dermatological conditions.

AI Generated. May Contain Errors.

Azitra Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
6th Percentile Overall Score

AZTR MarketRank™: 
0.289598108745 of 5 stars

Azitra scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Azitra.

  • Earnings Growth

    Earnings for Azitra are expected to grow in the coming year, from ($2.05) to ($0.64) per share.

  • Price to Book Value per Share Ratio

    Azitra has a P/B Ratio of 0.17. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    5.06% of the float of Azitra has been sold short.
  • Short Interest Ratio / Days to Cover

    Azitra has a short interest ratio ("days to cover") of 0.02, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Azitra has recently increased by 172.33%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Azitra does not currently pay a dividend.

  • Dividend Growth

    Azitra does not have a long track record of dividend growth.

  • News Sentiment

    Azitra has a news sentiment score of -0.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Azitra this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Azitra insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.28% of the stock of Azitra is held by insiders.

  • Percentage Held by Institutions

    11.16% of the stock of Azitra is held by institutions.

  • Read more about Azitra's insider trading history.
Receive AZTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Azitra and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AZTR Stock News Headlines

The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
Azitra (AZTR) Projected to Post Quarterly Earnings on Wednesday
Azitra Stock Sees Q3 Earnings Forecast Cut at Zacks Research
AZTR: Update on Rash, Fine Lines & Elasticity
See More Headlines

AZTR Stock Analysis - Frequently Asked Questions

Azitra's stock was trading at $2.6480 at the beginning of the year. Since then, AZTR stock has decreased by 77.0% and is now trading at $0.6084.

Azitra, Inc. (NYSEAMERICAN:AZTR) issued its quarterly earnings data on Thursday, November, 12th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.25) by $0.04.

Azitra's stock reverse split before market open on Friday, August 22nd 2025.The 100-666 reverse split was announced on Monday, August 11th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, August 21st 2025. An investor that had 100 shares of stock prior to the reverse split would have 15 shares after the split.

Shares of AZTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/12/2026
Today
11/15/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NYSEAMERICAN:AZTR
CIK
1701478
Fax
N/A
Employees
13
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$10.95 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-191.57%
Return on Assets
-155.52%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.11
Quick Ratio
3.11

Sales & Book Value

Annual Sales
$10 thousand
Price / Sales
368.69
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.54 per share
Price / Book
0.17

Miscellaneous

Outstanding Shares
6,060,000
Free Float
6,043,000
Market Cap
$3.69 million
Optionable
Not Optionable
Beta
-0.90
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (NYSEAMERICAN:AZTR) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners